Online citations, reference lists, and bibliographies.

Re: Marko Babjuk, Andreas Böhle, Maximilian Burger, Et Al. EAU Guidelines On Non-muscle-invasive Urothelial Carcinoma Of The Bladder: Update 2016. Eur Urol 2017;71:447-61.

H. Herr
Published 2017 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
The 2016 European Association of Urology guidelines on nonmuscle-invasive bladder cancer is exemplary; however, the definition of Bacillus Calmette–Guérin (BCG)-refractory remains confusing [1]. One BCG-refractory category (Table 9 in the European Association of Urology guidelines) lists ‘‘high-grade papillary tumor present at 3 mo, because further conservative treatment with BCG is associated with increased risk of progression.’’ Although common to determine BCG response after 3 mo [2], is this is too soon (only 6 wk after last dose of 6-weekly induction regimen) to
This paper references

This paper is referenced by
Bladder cancer recurrence surveillance by urine metabolomics analysis
A. Loras (2018)
PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive patients and BCG responders
Francesco Pierconti (2020)
Characterizing intermediate-risk non-muscle-invasive bladder cancer: Implications for the definition of intermediate risk and treatment strategy.
K. Matsumoto (2017)
Molecular Cytology Applications on Urine
S. Savic (2018)
Types of Cancer
Bansi Lal Koul (2019)
Urine cell-based DNA methylation classifier for monitoring bladder cancer
A. G. van der Heijden (2018)
Elaboration of a multisequence MRI-based radiomics signature for the preoperative prediction of the muscle-invasive status of bladder cancer: a double-center study
Huanjun Wang (2020)
Usefulness of the inchworm sign on DWI for predicting pT1 bladder cancer progression
Shugo Yajima (2019)
Psychosocial Distress in Bladder Cancer Stratified by Gender, Age, Treatment, and Tumour Stage
D. Draeger (2018)
Epidemiologie des Harnblasenkarzinoms in Deutschland
K. Kraywinkel (2017)
Nonmuscular Invasive Urothelial Carcinoma of the Bladder in Pediatric and Young Adult Patients: Age-related Outcomes.
Paolo Caione (2017)
Predicting complications following radical cystectomy with the ACS NSQIP universal surgical risk calculator
Miles P Mannas (2019)
Preliminary study on the application of en bloc resection combined with near-infrared molecular imaging technique in the diagnosis and treatment of bladder cancer
Yongjun Yang (2020)
Novel nomograms to predict recurrence and progression in primary non-muscle-invasive bladder cancer: validation of predictive efficacy in comparison with European Organization of Research and Treatment of Cancer scoring system
H. Kim (2018)
Die En-bloc-Resektion des Harnblasentumors
J. Struck (2017)
Wide-field autofluorescence-guided TUR-B for the detection of bladder cancer: a pilot study
Maximilian C. Kriegmair (2017)
Current Evidence of Transurethral En-bloc Resection of Nonmuscle Invasive Bladder Cancer.
M. Kramer (2017)
Altered expression of HER-2 and the mismatch repair genes MLH1 and MSH2 predicts the outcome of T1 high-grade bladder cancer
F. Sanguedolce (2018)
Blue Light Cystoscopy: Indications and Outcomes
Kamal S. Pohar (2020)
Robot-assisted Laparoscopic Implantation of Brachytherapy Catheters in Bladder Cancer.
J. Bosschieter (2018)
Urine Cytology and Existing Urinary Biomarkers for Bladder Cancer
T. Longo (2018)
Reply from Authors re: Peter Albers. Surveillance of Patients with Clinical Stage I Testis Cancer is Safe and Will Remain Unchanged. Eur Urol 2017;71:130-131.
Madhur Nayan (2017)
Liquid Biopsy Analysis of FGFR3 and PIK3CA Hotspot Mutations for Disease Surveillance in Bladder Cancer.
E. Christensen (2017)
A Novel Urine-Based Assay for Bladder Cancer Diagnosis: Multi-Institutional Validation Study.
N. Davis (2018)
When the Gold Standard Proves to Be Fool's Gold-Blue-light Cystoscopy in a Case of High-risk Non-muscle-invasive Bladder Cancer.
Kaitlyn M. Dunphy (2017)
Hexaminolevulinate: a profile of its use with blue-light cystoscopy in the diagnosis of bladder cancer
Katherine A. Lyseng-Williamson (2017)
The Current State of Predicting Response on Bacillus Calmette-Guérin Treatment for Nonmuscle Invasive Bladder Cancer is Not Yet Useful for Patients but Attributes to Understanding Its Mechanisms of Action.
Jorg R Oddens (2018)
Instillation postopératoire précoce de chimiothérapie après néphro-urétérectomie totale pour tumeur de la voie excrétrice urinaire supérieure
Pierre Colin (2016)
Efficacy, pharmacokinetic and pharmacodynamic evaluation of apaziquone in the treatment of non-muscle invasive bladder cancer
R. Phillips (2017)
Clinical Pathology of the Urinary Bladder
George Agrogiannis (2018)
Reply to Harry Herr's Letter to the Editor re: Marko Babjuk, Andreas Böhle, Maximilian Burger, et al. EAU Guidelines on Non-muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol 2017;71:447-61.
M. Babjuk (2017)
Antiplatelet İlaç Kullanımının Mesane Kanseri Tanısı Üzerindeki Etkileri: Kolaylaştırıcı mı, Zorlaştırıcı mı?
Haci Ibrahim Cimen (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar